Amanta Healthcare IPO
IPO Listing Details
- Listing Date
09 Sep 2025
- Listing Price
₹134.00
- Listing Change
6.35%
- Last Traded Price
₹104.30
Amanta Healthcare IPO Details
-
Open Date
01 Sep 2025
-
Close Date
03 Sep 2025
-
Listing Date
09 Sep 2025
- IPO Price Range
₹ 120 to ₹126
- IPO Size
₹ 126 Cr
- Listing Exchange
BSE NSE
Amanta Healthcare IPO Timeline
Amanta Healthcare IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 01-Sep-25 | 0.04 | 5.82 | 6.72 | 4.62 |
| 02-Sep-25 | 0.53 | 36.41 | 23.35 | 19.63 |
| 03-Sep-25 | 35.86 | 209.40 | 54.96 | 82.60 |
Last Updated: 03 September 2025 6:37 PM by 5paisa
Amanta Healthcare Limited, launching a ₹126.00 Cr IPO, is a pharmaceutical company specialising in the development, manufacturing, and marketing of sterile liquid and parenteral products, packaged using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. It also produces medical devices, including IV fluids, diluents, ophthalmic and respiratory care solutions, irrigation products, and eye lubricants. With over 45 generic products, Amanta Healthcare operates through national and international sales, as well as partnerships, distributing across India and exporting to 21 countries across Africa, Latin America, the UK, and beyond.
Established in: 1994
Managing Director: Mr. Bhavesh Patel
| Name of the company | Denis Chem Lab Limited | Amanta Healthcare Limited |
| Total Income (in Cr) | 175.67 | 276.09 |
| Face Value | 10.00 | 10.00 |
| P/E | 15.92 | [●] |
| CMP | 92.65 | [●] |
| Restated basic earnings/(loss) per share | 5.82 | 3.71 |
| Restated diluted earnings/(loss) per share | 5.82 | 3.71 |
| RoNW(%) | 9.49 | 10.89 |
| NAV per equity share, | 61.33 | 33.43 |
Amanta Healthcare Objectives
● The company will use ₹70.00 crores for SteriPort construction and machinery.
● ₹30.13 crores will support SVP line construction and equipment purchase.
● Remaining funds will be utilised for general corporate purposes.
Amanta Healthcare IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹126.00 Cr |
| Offer For Sale | - |
| Fresh Issue | ₹126.00 Cr |
Amanta Healthcare IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | 14,280 |
| Retail (Max) | 13 | 1,547 | 1,85,640 |
| S-HNI (Min) | 14 | 1,666 | 1,99,920 |
| S-HNI (MAX) | 66 | 7,854 | 9,42,480 |
| B-HNI (Min) | 67 | 7,973 | 9,56,760 |
Amanta Healthcare IPO Reservation
| Investors Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB | 35.86 | 20,00,000 | 7,17,22,490 | 903.70 |
| NII (HNI) | 209.40 | 15,00,000 | 31,41,06,093 | 3,957.74 |
| Retail | 54.96 | 35,00,000 | 19,23,55,051 | 2,423.67 |
| Total** | 82.60 | 70,00,000 | 57,81,83,634 | 7,285.11 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (in Rs. Crores) | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | 262.70 | 281.61 | 276.09 |
| EBITDA | 56.31 | 58.76 | 61.05 |
| PAT | -2.11 | 3.63 | 10.50 |
| Particulars (in Rs. Crores)] | FY23 | FY24 | FY25 |
|---|---|---|---|
| Total Assets | 374.06 | 352.12 | 381.76 |
| Share Capital | 26.83 | 26.83 | 28.83 |
| Total Borrowings | 215.66 | 205.23 | 195.00 |
| Particulars (in Rs. Crores | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net Cash Generated From / (used in) operating activities | 42.58 | 58.07 | 46.62 |
| Net Cash Generated From / (used in) investing activities | -6.53 | -10.32 | -24.47 |
| Net Cash Generated From / (used in) financing activities | -42.32 | -46.32 | -23.47 |
| Net Increase (Decrease) In Cash And Cash Equivalents | -6.3 | 1.4 | -1.3 |
Strengths
1. Strong expertise in sterile liquid and parenteral products.
2. Advanced ABFS and ISBM manufacturing technologies ensure quality.
3. Wide product portfolio across pharma and medical devices.
4. Established presence in India with 320 distributors.
Weaknesses
1. Heavy dependence on generic product portfolio limits differentiation.
2. Limited global registrations compared to larger pharma players.
3. Capital-intensive operations increase financial and operational risk.
4. Export revenues dependent on regulatory approvals and compliance.
Opportunities
1. Rising demand for IV fluids and ophthalmic solutions.
2. Expanding healthcare access in Africa and Latin America.
3. Scope for strategic partnerships with global pharmaceutical firms.
4. Increasing acceptance of cost-effective generic formulations worldwide.
Threats
1. Intense competition from domestic and multinational pharma companies.
2. Strict international regulations may delay product registrations.
3. Currency fluctuations can affect export revenue margins.
4. Technological obsolescence risks in manufacturing processes.
1. Strong presence in sterile liquid pharmaceutical segment.
2. Advanced technologies ensure consistent product quality standards.
3. Expanding international footprint across multiple global markets.
4. Robust distribution network with 320 Indian stockists.
Amanta Healthcare operates within the growing pharmaceutical and healthcare industry, driven by increasing demand for sterile liquid formulations, IV fluids, and medical devices. With advanced ABFS and ISBM technologies, the company caters to both domestic and international markets. Rising healthcare spending, expanding access in emerging economies, and regulatory compliance across multiple geographies position Amanta strongly for sustained growth and enhanced market presence in the coming years.
- Companies
- Type
- Opening On
-
Wakefit Innovations
- Mainboard
- 08th Dec
- Pre-Book
-
Corona Remedies
- Mainboard
- 08th Dec
- Pre-Book
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Amanta Healthcare IPO opens from September 1, 2025 to September 3, 2025.
The size of Amanta Healthcare IPO is ₹126.00 Cr.
The price band of Amanta Healthcare IPO is fixed at ₹120 to ₹126 per share.
To apply for Amanta Healthcare IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Amanta Healthcare IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Amanta Healthcare IPO is of 119 shares and the investment required is ₹14,994.
The share allotment date of Amanta Healthcare IPO is September 4, 2025
The Amanta Healthcare IPO will likely be listed on September 9, 2025.
Beeline Capital Advisors Pvt.Ltd is the book running lead manager for Amanta Healthcare IPO.
Amanta Healthcare plans to utilise the raised capital from the IPO for:
● The company will use ₹70.00 crores for SteriPort construction and machinery.
● ₹30.13 crores will support SVP line construction and equipment purchase.
● Remaining funds will be utilised for general corporate purposes.
Amanta Healthcare Contact Details
8th Floor, Shaligram Corporates
C.J. Marg
Ambli,
Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/
Amanta Healthcare IPO Register
Beeline Capital Advisors Pvt.Ltd.
Amanta Healthcare IPO Lead Manager
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: amantahealthcare.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html